PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2018
CASE
AUTH/3120/11/18 Shire

AUTH/3120/11/18: Director v Shire β€” Clinical trial disclosure (outwith scope; no breach)

PMCPA case AUTH/3120/11/18 (Director v Shire) about clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…

2018
CASE
AUTH/3077/9/18 Otsuka

AUTH/3077/9/18: Director v Otsuka UK β€” Clinical trial disclosure (outwith scope; no breach)

PMCPA case AUTH/3077/9/18 (Otsuka UK) concerned clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016). No…

2012
CASE
Merck Serono

Merck Serono: patient support website emails used for market research survey invitation (no breach)

A patient received a survey invite from a market research agency after registering on a Rebif support site. She alleged improper sharing…

2012
CASE
AUTH/2500/4/12 Eisai ⭐ Case of the Week

Eisai breached ABPI Code over Zonegran detail aid implying weight-loss benefit (AUTH/2500/4/12)

Anonymous neurologist alleged Zonegran promotion implied use in overweight epileptics. PMCPA found the detail aid misleading on weight effects, exaggerating properties and…

2011
CASE
AUTH/2478/2/11 GlaxoSmithKline

GSK Seretide pricing and NHS β€œvalue” email: complaint not upheld (AUTH/2478/2/11)

A pharmacist challenged GSK claims that Seretide was β€œpriced competitively” and could help NHS QIPP targets. The PMCPA Panel found both claims…

2011
CASE
AUTH/2442/10/11 Vifor Pharma

AUTH/2442/10/11: Pharmacosmos v Vifor β€” breach of undertaking over Ferinject hypersensitivity claim in website press releases

Vifor left two website press releases live containing a Ferinject claim previously ruled misleading about hypersensitivity. PMCPA found a breach of undertaking…

2011
CASE
AUTH/2435/8/11 Chiesi

AUTH/2435/8/11: Chiesi ruled in breach for promoting Fostair in COPD at an international symposium and for breaching an undertaking

GSK alleged Chiesi promoted Fostair for COPD before UK authorisation via an ATS symposium and a sponsored journal. PMCPA found off-label promotion,…

2012
CASE
Recordati

Recordati: ISU Belfast urology meeting sponsorship criticised due to overall impression of luxury venue and social programme (Clause 9.1 breach)

Anonymous NHS HCPs complained about excessive hospitality at an ISU meeting in Belfast (5-star venue, golf, gala dinner). For Recordati, PMCPA found…

2013
CASE
AUTH/2603/5/13 Roche Products ⭐ Case of the Week

Roche: hotel bar drinks and dinner around BSH meeting logistics discussion found disproportionate (AUTH/2603/5/13)

Anonymous complaint about Roche buying drinks in a hotel bar during BSH 2013. Panel found one instance (Sunday pre-conference bar drinks plus…

2013
CASE
AUTH/2583/3/13 Leo Pharma

Leo Pharma Picato BMJ ad: β€œrevolutionary”/β€œshortest duration” claim and imagery found misleading (AUTH/2583/3/13)

A Picato journal ad using β€œThe revolutionary, shortest duration…” plus a high-speed train implied broader indication and faster effect. PMCPA found breaches…

2013
CASE
AUTH/2637/9/13 Sanofi

Sanofi Lyxumia β€œSpeaker Club” invite: unclear email created impression of Β£1,000 for attending a promotional meeting (AUTH/2637/9/13)

Sanofi invited HCPs to a Lyxumia Speaker Club and referenced Β£1,000 payment. Panel found no inducement/payment breach on the narrow allegation, but…

2013
CASE
AUTH/2606/5/13 Takeda

AUTH/2606/5/13: General Practitioner v Takeda β€” Prostap meeting Q&A (no breach)

A GP alleged a Takeda-sponsored meeting speaker said Prostap injection route β€œdid not matter”, implying off-licence promotion. Panel found evidence insufficient on…

2012
CASE
Flynn Pharma

Flynn Pharma: Circadin ad claim β€˜Current guidance states…’ ruled misleading (Clause 7.2)

A Circadin journal ad said β€œCurrent guidance states…” but the source was a BAP consensus statement, not NICE/AWMSG. The Panel found the…

2013
CASE
AUTH/2640/9/13 ⭐ Case of the Week

Anonymous v Nicoventures (AUTH/2640/9/13): Call rates set pre-licence for advance notification – no breach

MHRA referred a complaint that Nicoventures set pre-licence call rates for HDMs ahead of Voke’s authorisation. Panel found advance budget notification was…

2016
CASE
AUTH/2821/2/16 Sanofi

Sanofi Genzyme: patient organisation guests at BIA gala dinners ruled inappropriate hospitality (AUTH/2821/2/16)

Sanofi Genzyme admitted inviting patient organisation members to BIA gala dinners (2014/2015) with significant hospitality and likely >Β£75 subsistence, without clear educational…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training